Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000214214

Medchemexpress LLC CPI-1189 | 183619-38-7 | 99.8% | 234.29 g/mol | C13H18N2O2 | 100 MG
SDP

Supplier:  Medchemexpress LLC HY100376100MG

Encompass_Preferred

CPI-1189 is an orally active TNF-α release inhibitor that suppresses p38 MAP kinase phosphorylation and has demonstrated anti-apoptotic activity. It is used in preclinical research on inflammatory signaling, HIV, and neurological disease models.

  • Orally active TNF-α release inhibitor suitable for in vitro and in vivo studies.
  • Inhibits p38 phosphorylation, useful for signaling pathway research.
  • Demonstrated anti-apoptotic activity in relevant models.
  • High purity (99.82%) solid, white to off-white powder.
  • Stable when stored at -20°C as powder and under recommended solvent conditions.
  • Available in small research pack sizes to support dose-ranging experiments.

Catalog No. 50-002-14214


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.